Asbestos-induced endothelial cell activation and injury. Demonstration of fiber phagocytosis and oxidant-dependent toxicity

Joe GN Garcia, L. D. Gray, R. F. Dodson, K. S. Callahan

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Vascular endothelial cell injury is important in the development of a variety of chronic interstitial lung disorders. However, the involvement of such injury in the inflammatory response associated with the inhalation of asbestos fibers is unclear and the mechanism of asbestos fiber cytotoxicity remains unknown. In the present study, human umbilical vein endothelial cells were challenged with amosite asbestos and several parameters of cellular function were examined. Electron microscopic examination revealed that endothelial cell exposure to asbestos resulted in active phagocytosis of these particulates. Biochemical evidence of dose-dependent asbestos-mediated endothelial cell activation was indicated by increased metabolism of arachidonic acid. For example, amosite asbestos (500 μg/ml) produced a ninefold increase in prostacyclin (PGI2) levels over those levels in non-exposed cells. Incubation of human endothelial cells with asbestos fibers induced specific 51Cr release in both a dose- and time-dependent fashion indicative of cellular injury. Injury induced by amosite asbestos was not significantly attenuated by treatment of the endothelial cell monolayer with either the iron chelator deferoxamine, which prevents hydroxyl radical (·OH) formation, or by the superoxide anion (O2-) scavenger, superoxide dismutase. However, significant dose-dependent protection was observed with the hydrogen peroxide (H2O2) scavenger, catalase. Chelation of elemental iron present within amosite asbestos fibers by deferoxamine produced a 33% reduction in asbestos cytotoxicity, suggesting a potential role for hydroxyl radical-mediated injury via the iron-catalyzed Haber-Weiss reaction. Maximal endothelial cell protection against fiber cytotoxicity was found with the combination of catalase (3,000 U/ml) and deferoxamine-treated amosite asbestos, which reduced asbestos-induced 51Cr release by 87 ± 3%. In addition, the asbestos-stimulated release of PGI2 was significantly attenuated by both the concomitant treatment of endothelial monolayers with catalase, as well as the use of deferoxamine-treated asbestos. Thus, asbestos-induced endothelial cell injury and alterations in cell function would appear to be mediated via oxidant-dependent mechanisms. These studies suggest that asbestos activated endothelial cells and that these target cells may be important participants in the inflammatory response associated with in vivo asbestos exposure.

Original languageEnglish (US)
Pages (from-to)958-964
Number of pages7
JournalAmerican Review of Respiratory Disease
Volume138
Issue number4
StatePublished - 1988
Externally publishedYes

Fingerprint

Asbestos
Phagocytosis
Oxidants
Endothelial Cells
Amosite Asbestos
Wounds and Injuries
Deferoxamine
Epoprostenol
Catalase
Iron
Hydroxyl Radical
Cytoprotection
Human Umbilical Vein Endothelial Cells
Chelating Agents
Arachidonic Acid
Superoxides
Hydrogen Peroxide
Inhalation
Superoxide Dismutase
Electrons

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Asbestos-induced endothelial cell activation and injury. Demonstration of fiber phagocytosis and oxidant-dependent toxicity. / Garcia, Joe GN; Gray, L. D.; Dodson, R. F.; Callahan, K. S.

In: American Review of Respiratory Disease, Vol. 138, No. 4, 1988, p. 958-964.

Research output: Contribution to journalArticle

@article{76cfd30f4b89438695ea0e078673ff2e,
title = "Asbestos-induced endothelial cell activation and injury. Demonstration of fiber phagocytosis and oxidant-dependent toxicity",
abstract = "Vascular endothelial cell injury is important in the development of a variety of chronic interstitial lung disorders. However, the involvement of such injury in the inflammatory response associated with the inhalation of asbestos fibers is unclear and the mechanism of asbestos fiber cytotoxicity remains unknown. In the present study, human umbilical vein endothelial cells were challenged with amosite asbestos and several parameters of cellular function were examined. Electron microscopic examination revealed that endothelial cell exposure to asbestos resulted in active phagocytosis of these particulates. Biochemical evidence of dose-dependent asbestos-mediated endothelial cell activation was indicated by increased metabolism of arachidonic acid. For example, amosite asbestos (500 μg/ml) produced a ninefold increase in prostacyclin (PGI2) levels over those levels in non-exposed cells. Incubation of human endothelial cells with asbestos fibers induced specific 51Cr release in both a dose- and time-dependent fashion indicative of cellular injury. Injury induced by amosite asbestos was not significantly attenuated by treatment of the endothelial cell monolayer with either the iron chelator deferoxamine, which prevents hydroxyl radical (·OH) formation, or by the superoxide anion (O2-) scavenger, superoxide dismutase. However, significant dose-dependent protection was observed with the hydrogen peroxide (H2O2) scavenger, catalase. Chelation of elemental iron present within amosite asbestos fibers by deferoxamine produced a 33{\%} reduction in asbestos cytotoxicity, suggesting a potential role for hydroxyl radical-mediated injury via the iron-catalyzed Haber-Weiss reaction. Maximal endothelial cell protection against fiber cytotoxicity was found with the combination of catalase (3,000 U/ml) and deferoxamine-treated amosite asbestos, which reduced asbestos-induced 51Cr release by 87 ± 3{\%}. In addition, the asbestos-stimulated release of PGI2 was significantly attenuated by both the concomitant treatment of endothelial monolayers with catalase, as well as the use of deferoxamine-treated asbestos. Thus, asbestos-induced endothelial cell injury and alterations in cell function would appear to be mediated via oxidant-dependent mechanisms. These studies suggest that asbestos activated endothelial cells and that these target cells may be important participants in the inflammatory response associated with in vivo asbestos exposure.",
author = "Garcia, {Joe GN} and Gray, {L. D.} and Dodson, {R. F.} and Callahan, {K. S.}",
year = "1988",
language = "English (US)",
volume = "138",
pages = "958--964",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "4",

}

TY - JOUR

T1 - Asbestos-induced endothelial cell activation and injury. Demonstration of fiber phagocytosis and oxidant-dependent toxicity

AU - Garcia, Joe GN

AU - Gray, L. D.

AU - Dodson, R. F.

AU - Callahan, K. S.

PY - 1988

Y1 - 1988

N2 - Vascular endothelial cell injury is important in the development of a variety of chronic interstitial lung disorders. However, the involvement of such injury in the inflammatory response associated with the inhalation of asbestos fibers is unclear and the mechanism of asbestos fiber cytotoxicity remains unknown. In the present study, human umbilical vein endothelial cells were challenged with amosite asbestos and several parameters of cellular function were examined. Electron microscopic examination revealed that endothelial cell exposure to asbestos resulted in active phagocytosis of these particulates. Biochemical evidence of dose-dependent asbestos-mediated endothelial cell activation was indicated by increased metabolism of arachidonic acid. For example, amosite asbestos (500 μg/ml) produced a ninefold increase in prostacyclin (PGI2) levels over those levels in non-exposed cells. Incubation of human endothelial cells with asbestos fibers induced specific 51Cr release in both a dose- and time-dependent fashion indicative of cellular injury. Injury induced by amosite asbestos was not significantly attenuated by treatment of the endothelial cell monolayer with either the iron chelator deferoxamine, which prevents hydroxyl radical (·OH) formation, or by the superoxide anion (O2-) scavenger, superoxide dismutase. However, significant dose-dependent protection was observed with the hydrogen peroxide (H2O2) scavenger, catalase. Chelation of elemental iron present within amosite asbestos fibers by deferoxamine produced a 33% reduction in asbestos cytotoxicity, suggesting a potential role for hydroxyl radical-mediated injury via the iron-catalyzed Haber-Weiss reaction. Maximal endothelial cell protection against fiber cytotoxicity was found with the combination of catalase (3,000 U/ml) and deferoxamine-treated amosite asbestos, which reduced asbestos-induced 51Cr release by 87 ± 3%. In addition, the asbestos-stimulated release of PGI2 was significantly attenuated by both the concomitant treatment of endothelial monolayers with catalase, as well as the use of deferoxamine-treated asbestos. Thus, asbestos-induced endothelial cell injury and alterations in cell function would appear to be mediated via oxidant-dependent mechanisms. These studies suggest that asbestos activated endothelial cells and that these target cells may be important participants in the inflammatory response associated with in vivo asbestos exposure.

AB - Vascular endothelial cell injury is important in the development of a variety of chronic interstitial lung disorders. However, the involvement of such injury in the inflammatory response associated with the inhalation of asbestos fibers is unclear and the mechanism of asbestos fiber cytotoxicity remains unknown. In the present study, human umbilical vein endothelial cells were challenged with amosite asbestos and several parameters of cellular function were examined. Electron microscopic examination revealed that endothelial cell exposure to asbestos resulted in active phagocytosis of these particulates. Biochemical evidence of dose-dependent asbestos-mediated endothelial cell activation was indicated by increased metabolism of arachidonic acid. For example, amosite asbestos (500 μg/ml) produced a ninefold increase in prostacyclin (PGI2) levels over those levels in non-exposed cells. Incubation of human endothelial cells with asbestos fibers induced specific 51Cr release in both a dose- and time-dependent fashion indicative of cellular injury. Injury induced by amosite asbestos was not significantly attenuated by treatment of the endothelial cell monolayer with either the iron chelator deferoxamine, which prevents hydroxyl radical (·OH) formation, or by the superoxide anion (O2-) scavenger, superoxide dismutase. However, significant dose-dependent protection was observed with the hydrogen peroxide (H2O2) scavenger, catalase. Chelation of elemental iron present within amosite asbestos fibers by deferoxamine produced a 33% reduction in asbestos cytotoxicity, suggesting a potential role for hydroxyl radical-mediated injury via the iron-catalyzed Haber-Weiss reaction. Maximal endothelial cell protection against fiber cytotoxicity was found with the combination of catalase (3,000 U/ml) and deferoxamine-treated amosite asbestos, which reduced asbestos-induced 51Cr release by 87 ± 3%. In addition, the asbestos-stimulated release of PGI2 was significantly attenuated by both the concomitant treatment of endothelial monolayers with catalase, as well as the use of deferoxamine-treated asbestos. Thus, asbestos-induced endothelial cell injury and alterations in cell function would appear to be mediated via oxidant-dependent mechanisms. These studies suggest that asbestos activated endothelial cells and that these target cells may be important participants in the inflammatory response associated with in vivo asbestos exposure.

UR - http://www.scopus.com/inward/record.url?scp=0023749649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023749649&partnerID=8YFLogxK

M3 - Article

VL - 138

SP - 958

EP - 964

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 4

ER -